You are using an outdated browser. We suggest you update your browser for a better experience. Click here for update.
Close this notification.
Skip to main content Skip to search

 

50 Results
Document
These frequently asked questions give patients and their families information about the services and safeguards we use for our web-based symptom...
Cancer facts
Mar 2012
Document
Aug 2017
Guidelines and Advice
Status: Current
ID: GL-C50-09
Jun 2019
Guidelines and Advice
Status: Current
ID: GL-C50-15
Jun 2014
Drug
Other Name(s): Kadcyla®
Quick Link(s): Drug Monograph, Patient Info Sheet
Aug 2023
Regimen
Cancer Type:
Breast
Show More Show more tags
, Show Less Show fewer tags
Intent: Palliative
Funding:
New Drug Funding Program
    Trastuzumab Emtansine - Unresectable Locally Advanced or Metastatic Breast Cancer
Show More Show more tags
, Show Less Show fewer tags
Drugs Used:
Kadcyla trastuzumab emtansine
... Show more tags
, Collapse Show fewer tags
Quick Link(s):
Regimen Monograph
Aug 2023
Document
Jan 2018
Document
Feb 2018

Pages